PLAGL2 promotes HCC progression by recruiting tumour‐associated macrophages via CCL2/CCR2 signalling
Year: 2025
Type: article
Language: en
Topic: Immune cells in cancer
Authors and affiliations:
raw_author_name: Yumeng Shen
raw_affiliation_strings: State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China
raw_author_name: Dongqing Zhai
raw_affiliation_strings: Center for New Drug Safety Evaluation and Research China Pharmaceutical University  Nanjing China
Institute of Translational Medicine China Pharmaceutical University  Nanjing China
State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China
raw_author_name: Weijun Zhao
raw_affiliation_strings: Center for New Drug Safety Evaluation and Research China Pharmaceutical University  Nanjing China
Institute of Translational Medicine China Pharmaceutical University  Nanjing China
State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China
raw_author_name: Yuyuan Chen
raw_affiliation_strings: Center for New Drug Safety Evaluation and Research China Pharmaceutical University  Nanjing China
Institute of Translational Medicine China Pharmaceutical University  Nanjing China
School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University  Nanjing China
State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China
raw_author_name: Jiaping Ni
raw_affiliation_strings: Center for New Drug Safety Evaluation and Research China Pharmaceutical University  Nanjing China
Institute of Translational Medicine China Pharmaceutical University  Nanjing China
State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China
raw_author_name: Jingtong Li
raw_affiliation_strings: Center for New Drug Safety Evaluation and Research China Pharmaceutical University  Nanjing China
School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University  Nanjing China
State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China
raw_author_name: Zijie Wu
raw_affiliation_strings: Institute of Translational Medicine China Pharmaceutical University  Nanjing China
State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China
raw_author_name: Yanchao Xu
raw_affiliation_strings: Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School  Nanjing China
raw_author_name: Binghua Li
raw_affiliation_strings: Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School  Nanjing China
raw_author_name: Shentian Zhuang
raw_affiliation_strings: Center for New Drug Safety Evaluation and Research China Pharmaceutical University  Nanjing China
Institute of Translational Medicine China Pharmaceutical University  Nanjing China
School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University  Nanjing China
State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China
raw_author_name: Weiwei Hu
raw_affiliation_strings: Center for New Drug Safety Evaluation and Research China Pharmaceutical University  Nanjing China
Lingang Laboratory  Shanghai China
School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University  Nanjing China
State Key Laboratory of Natural Medicines China Pharmaceutical University  Nanjing China